Literature DB >> 12135804

Pathobiochemistry and clinical use of procalcitonin.

Michael Meisner1.   

Abstract

Induction of the protein procalcitonin during infection and inflammation was first described approximately 10 years ago. A large number of publications, primarily clinical studies, demonstrate the increasing use of procalcitonin in modern clinical practice. However, data on the biological function and origin of procalcitonin is scarce. Findings regarding the possible role and source of procalcitonin in sepsis and infection were recently published, and the pathophysiology of the protein has meanwhile been investigated in various experimental models. Procalcitonin obviously has certain biological functions, and it is also known to be specifically induced. Given the hormonal origin of the mature protein and the inflammation-related functions of its propeptides, some investigators suggest that procalcitonin should be referred to as a "hormokine," although its biological functions should be studied in more detail. This review will survey the data now available in recent publications on the induction, production sources, possible biological functions and clinical uses of procalcitonin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12135804     DOI: 10.1016/s0009-8981(02)00101-8

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  61 in total

Review 1.  Postmortem chemistry update part II.

Authors:  Cristian Palmiere; Patrice Mangin
Journal:  Int J Legal Med       Date:  2011-10-09       Impact factor: 2.686

2.  Diagnostic use of serum procalcitonin levels in pulmonary aspiration syndromes.

Authors:  Ali A El-Solh; Hardik Vora; Paul R Knight; Jahan Porhomayon
Journal:  Crit Care Med       Date:  2011-06       Impact factor: 7.598

Review 3.  Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis.

Authors:  H Tang; T Huang; J Jing; H Shen; W Cui
Journal:  Infection       Date:  2009-10-13       Impact factor: 3.553

Review 4.  Overview of procalcitonin in pregnancy and in pre-eclampsia.

Authors:  A Mangogna; C Agostinis; G Ricci; F Romano; R Bulla
Journal:  Clin Exp Immunol       Date:  2019-06-13       Impact factor: 4.330

5.  Predictive value of procalcitonin for the diagnosis of bowel strangulation.

Authors:  Refik Ayten; Osman Dogru; Cemalettin Camci; Erhan Aygen; Ziya Cetinkaya; Handan Akbulut
Journal:  World J Surg       Date:  2005-02       Impact factor: 3.352

6.  The use of procalcitonin as a marker of sepsis in children.

Authors:  Bin Mathew; Dinesh Roy D; T Vijaya Kumar
Journal:  J Clin Diagn Res       Date:  2013-02-01

7.  Is procalcitonin a marker of invasive bacterial infection in acute sickle-cell vaso-occlusive crisis?

Authors:  K Stankovic Stojanovic; O Steichen; F Lionnet; C Bachmeyer; I Lecomte; V Avellino; G Grateau; R Girot; G Lefevre
Journal:  Infection       Date:  2011-01-11       Impact factor: 3.553

Review 8.  Biomarkers in the diagnosis of aspiration syndromes.

Authors:  Philippe Abou Jaoude; Paul R Knight; Patricia Ohtake; Ali A El-Solh
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

Review 9.  Procalcitonin: improved biochemical severity stratification and postoperative monitoring in severe abdominal inflammation and sepsis.

Authors:  B Rau; C M Krüger; M K Schilling
Journal:  Langenbecks Arch Surg       Date:  2004-03-06       Impact factor: 3.445

10.  Procalcitonin versus C-reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care.

Authors:  Anette Holm; Svend S Pedersen; Joergen Nexoe; Niels Obel; Lars P Nielsen; Ole Koldkjaer; Court Pedersen
Journal:  Br J Gen Pract       Date:  2007-07       Impact factor: 5.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.